The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 07, 2023

Filed:

Dec. 01, 2017
Applicants:

The Uab Research Foundation, Birmingham, AL (US);

The University of Tokyo, Tokyo, JP;

Inventors:

David E. Briles, Birmingham, AL (US);

Hiroshi Kiyono, Tokyo, JP;

Robert Kneller, Tokyo, JP;

Reshmi Mukerji, Birmingham, AL (US);

Kristopher Genschmer, Irondale, AL (US);

Yoshikazu Yuki, Tokyo, JP;

Assignees:

The UAB Research Foundation, Birmingham, AL (US);

The University of Tokyo, Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/09 (2006.01); A61P 31/04 (2006.01); C07K 14/315 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/092 (2013.01); A61P 31/04 (2018.01); C07K 14/3156 (2013.01); A61K 2039/54 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55583 (2013.01);
Abstract

The present embodiments provide compositions and methods related to novel recombinant protein immunogens, comprising specific portions of alpha helical domains (aHD) and proline rich regions (PRD) of pneumococcal surface protein A (PspA), which portions are linked to provide aHD-PRD constructs. The aHD and PRD proteins constituting the aHD-PRD constructs are selected to maximize cross-reactivity and provide protection against a broad spectrum of pneumococcal serotypes. Immunogenic compositions, including vaccines, comprising at least one aHD PRD construct may also include a non-linked aHD portion. Also provided are recombinant nucleic acid molecules that encode aHD-PRD constructs, vectors and recombinant host cells containing such molecules, aHD-PRD expression products, use of such nucleic acid molecules to express aHD-PRD constructs by recombinant techniques, and use of the expression products to elicit an immune or protective response against pneumococcal disease in a suitable host.


Find Patent Forward Citations

Loading…